18 Nov 2020 15:11
UK DIRECTOR DEALINGS SUMMARY: 888 CEO Sells GBP780,000 In Shares
UK DIRECTOR DEALINGS SUMMARY: 888 CEO Sells GBP780,000 In Shares
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
TILS.L Share News (TILS)
TILS Share
Price
TILS Share
News
TILS Share
Chat
TILS Share
Trades
TILS
Live RNS
TILS Share
Charts
TILS Broker
Ratings
TILS Directors
Deals
TILS Financial
Diary
TILS
Fundamentals
TILS Short
Positions
TILS
Media
TILS.L Information
- There is currently no data for TILS
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.11 Nov 2020 20:17
UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
UK TRADING UPDATE SUMMARY: Mereo To Delist From AIM Amid Nasdaq Focus
Read more2 Nov 2020 18:14
IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients
IN BRIEF: Tiziana To Start Brazil Clinical Trial For Covid-19 Patients
Read more29 Oct 2020 16:04
Court gives Tiziana capital reduction the nod
(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Thursday that the capital reduction required for the demerger of StemPrintER Sciences, and to enable the ultimate allotment of Accustem Sciences shares to its shareholders, has been sanctioned by the court.
Read more30 Sep 2020 12:18
UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim
UK EARNINGS SUMMARY: City Pub In Signs Of Recovery After Tough Interim
Read more25 Sep 2020 16:05
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more17 Sep 2020 15:51
IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab
IN BRIEF: Tiziana To Kick Off Clinical Study On Foralumab
Read more16 Sep 2020 11:55
Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets
Tiziana Plans 2020 London IPO Of StemPrintER, SPARE Assets
Read more24 Aug 2020 14:33
IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19
IN BRIEF: Tiziana Life Sciences Gets US Patent On TZLS-501 In Covid-19
Read more24 Aug 2020 14:19
Tiziana gets US patent for 'TZLS-501' antibody
(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that the United States Patent and Trademark Office (USPTO) has granted a patent for methods and use of fully human monoclonal antibody 'TZLS-501' that recognised both IL-6 receptor (IL-6R) and IL-6 receptor complex with IL-6 (IL-6R/IL-6) for prophylactic and therapeutic intervention for human diseases.
Read more21 Aug 2020 09:34
Tiziana Life Sciences Gets US Patent For Milciclib In Cancer
Tiziana Life Sciences Gets US Patent For Milciclib In Cancer
Read more18 Aug 2020 18:36
IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment
IN BRIEF: Tiziana Gets US Patent For Foralumab As Crohn's Treatment
Read more5 Aug 2020 22:03
UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination
UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination
Read more4 Aug 2020 19:16
UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
Read more4 Aug 2020 11:07
Tiziana inks four deals for development of Covid-19 treatment
(Sharecast News) - Biotechnology company Tiziana Life Sciences has signed agreements with four contract research organisations, it announced on Tuesday, to expedite the clinical development of 'TZLS-501' - a novel, fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for the treatment of Covid-19 patients.
Read more